Your browser doesn't support javascript.
loading
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial.
Hall, Peter S; Smith, Alison; Hulme, Claire; Vargas-Palacios, Armando; Makris, Andreas; Hughes-Davies, Luke; Dunn, Janet A; Bartlett, John M S; Cameron, David A; Marshall, Andrea; Campbell, Amy; Macpherson, Iain R; Francis, Adele; Earl, Helena; Morgan, Adrienne; Stein, Robert C; McCabe, Christopher.
Affiliation
  • Hall PS; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. Electronic address: p.s.hall@ed.ac.uk.
  • Smith A; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
  • Hulme C; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
  • Vargas-Palacios A; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
  • Makris A; Department of Clinical Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Northwood, UK.
  • Hughes-Davies L; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Dunn JA; Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.
  • Bartlett JMS; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Cameron DA; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK.
  • Marshall A; Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.
  • Campbell A; Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.
  • Macpherson IR; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK.
  • Dan Rea; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Francis A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Earl H; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Morgan A; Independent Cancer Patients' Voice, London, UK.
  • Stein RC; National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK.
  • McCabe C; University of Alberta, Edmonton, Alberta, Canada.
Value Health ; 20(10): 1311-1318, 2017 12.
Article in En | MEDLINE | ID: mdl-29241890

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Decision Support Techniques / Quality-Adjusted Life Years / Molecular Diagnostic Techniques Type of study: Clinical_trials / Diagnostic_studies / Health_economic_evaluation / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2017 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Decision Support Techniques / Quality-Adjusted Life Years / Molecular Diagnostic Techniques Type of study: Clinical_trials / Diagnostic_studies / Health_economic_evaluation / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2017 Type: Article